

Pondera Pharmaceuticals, Revenue
Pharmaceutical Manufacturing • United States • 1-10 Employees
Pondera Pharmaceuticals, revenue & valuation
| Annual revenue | $171,110 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Pharmaceutical Manufacturing industry and current estimated revenues | $547,552 |
| Total funding | No funding |
Key Contact at Pondera Pharmaceuticals,
William Crain
Co-Owner
Company overview
| Headquarters | United States |
| Website | |
| NAICS | 3254 |
| SIC | 283 |
| Founded | 2009 |
| Employees | 1-10 |
| Socials |
About Pondera Pharmaceuticals,
Endorphinate® is best used daily to maintain healthy levels of endorphins and balanced receptors to enhance an adaptive response to life’s stresses. While many people immediately experience a calming relief from emotional and physical distress, as well as enhanced energy and mental clarity, the real benefits of Endorphinate® become more evident over time. A healthy balanced endorphin system provides an ability to handle life’s stresses more effectively, allowing us to take charge of our life and make healthier choices rather than be driven by reactive emotional distress. As a result, we are more able to truly experience the natural satisfaction, pleasure, and joy of living that comes from a healthy adaptive approach to life.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
Pondera Pharmaceuticals, has never raised funding before.
Frequently asked questions
4.8
40,000 users



